Europe: Fast Emerging as the Hub for miRNA
Europe is fast emerging as the hub for miRNA based research and has accounted for almost 30% of the miRNA market generated in the year 2012. This market is expected to grow at a CAGR of 19.5% till 2018. Most of the ongoing or completed studies in Europe are based on various types of cancer, with main focus on Melanoma and Breast Cancer followed closely by leukemia, renal and ovarian cancer. Other major areas of interest in Europe include Obesity,...
View full press release